a pharmaceutical company, which engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease
Industry Biotechnology
A.I.dvisor indicates that over the last year, HEPA has been loosely correlated with AVIR. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HEPA jumps, then AVIR could also see price increases.
Ticker / NAME | Correlation To HEPA | 1D Price Change % | ||
---|---|---|---|---|
HEPA | 100% | -1.28% | ||
AVIR - HEPA | 45% Loosely correlated | +1.94% | ||
KRYS - HEPA | 33% Poorly correlated | +0.85% | ||
MPSYF - HEPA | 28% Poorly correlated | N/A | ||
PASG - HEPA | 25% Poorly correlated | -7.15% | ||
EXAI - HEPA | 23% Poorly correlated | N/A | ||
More |